Brian John Meakin

This inventor holds 14 USPTO granted patents, plus 1 CIPO patent and 10 EPO patents, primarily in Pharmaceutical Formulations. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2005-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian John Meakin. Retrieved from https://idiyas.com/inventor/brian-john-meakin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14

% Patents Active = 35.7

CIPO Patents = 1

EPO Patents = 10 (Patent Applications = 6)

Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 88(Granted Patents)

Location History:

Bath, GB (2006 - 2014)
Parma, IT (2005 - 2022)

Company Filing History:

14 out of 343

Chiesi Farmaceutici S.p.a.

patents

Years Active: 2005-2022

Loading Chart...

Areas of Expertise:

Pharmaceutical Formulations

Aerosol Compositions

Metered Dose Inhalers

Formoterol

Salmeterol

Ipratropium Bromide

HFA Propellant

Sequestering Agent

Chronic Obstructive Pulmonary Disease

Superfine Formulation

Stable Solutions

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11213485 - Pharmaceutical solution formulations for pressurized metered dose inhalers (2022-01-04),

2. 10525006 - Pharmaceutical solution formulations for pressurised metered dose inhalers (2020-01-07),

3. 8877164 - Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent (2014-11-04),

4. 8420058 - Pharmaceutical aerosol composition (2013-04-16),

5. 8313732 - Formoterol superfine formulation (2012-11-20),

6. 8142763 - Pressurized metered dose inhalers (MDI) containing a solution comprising ipratropium bromide, HFA propellant, and co-solvent and comprising a container with a specific internal surface composition and/or lining (2012-03-27),

7. 8088362 - Salmeterol superfine formulation (2012-01-03),

8. 7740463 - Pressurised metered dose inhalers (MDI) (2010-06-22),

9. 7601336 - Pharmaceutical aerosol composition (2009-10-13),

10. 7381402 - Stable pharmaceutical solution formulations for pressurized metered dose inhalers (2008-06-03),

11. 7347199 - Pressurised metered dose inhalers (MDI) (2008-03-25),

12. 7223381 - Pressurised metered dose inhalers (MDI) (2007-05-29),

13. 7018618 - Stable pharmaceutical solution formulations for pressurized metered dose inhalers (2006-03-28),

14. 6964759 - Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease (2005-11-15),

Title: Brian John Meakin: Innovator in Pharmaceutical Solutions

Introduction

Brian John Meakin, a dedicated inventor based in Parma, Italy, is known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 14 patents, he has made strides in developing innovative solutions aimed at treating severe broncho-pulmonary diseases. His expertise and dedication to research are evident in his latest inventions.

Latest Patents

Among his most recent patents are groundbreaking formulations for pressurized metered dose inhalers. These inventions focus on the prevention and/or treatment of severe broncho-pulmonary diseases by administering solution formulations that allow for the delivery of therapeutic doses. Notably, all active drug substances are fully dissolved, and they are delivered with substantially the same particle size distribution, enhancing their efficacy in therapeutic applications.

Career Highlights

Brian is currently employed at Chiesi Farmaceutici S.p.A., where he plays a pivotal role in advancing pharmaceutical technologies. His commitment to innovation in this company has contributed significantly to the industry.

Collaborations

Throughout his career, Brian has collaborated with talented professionals such as David Andrew Lewis and Gaetano Brambilla. These partnerships have fostered an environment conducive to innovation and have propelled the development of effective pharmaceutical solutions.

Conclusion

Brian John Meakin stands out as a prominent figure in the pharmaceutical industry, leveraging his inventive spirit to create formulations that improve health outcomes for patients suffering from respiratory illnesses. His inventions not only showcase his expertise but also highlight the importance of collaboration in the realm of innovative research and development.

Profile summary based on public USPTO records.